Japanese drugmaker Astellas Pharma plans to build an aseptic drug products facility in County Kerry, Ireland, creating an estimated 350 engineering, science, technology...
Japanese drugmaker Astellas Pharma has agreed to buy US bioelectronics startup Iota Biosciences. The move follows their R&D agreement signed in August 2019, under which...
16.08.2018
- Japan’s Astellas Pharma has acquired Cambridge, UK-based Quethera, a gene therapy company focused on developing novel treatments for eye disease, such as glaucoma. The acquisition...
28.06.2017
- The Association of the British Pharmaceutical Industry (ABPI) has suspended Astellas UK’s membership for a further 12 months from Jun. 24 because of several serious breaches of its...
08.06.2015
- On June 2, The International Society for Pharmaceutical Engineering (ISPE) formally appreciated its 2015 Facility of the Year Awards (FOYA) category winners at a banquet in...
03.11.2014
- Dutch genetic testing specialist Qiagen has signed a master collaboration agreement with Astellas Pharma, a Japanese R&D-driven global pharmaceutical company, to develop and...
21.11.2013
- The U.S. Food and Drug Administration warned physicians on Wednesday that two chemicals used to conduct cardiovascular stress tests can cause heart attacks and death, and it...
18.07.2013
- China announced a nationwide crackdown on the sale of illegal medicine on Wednesday and said it would tighten industry regulation, piling pressure on a sector already reeling from...
